Silk Peptide Ameliorates Sarcopenia through the Regulation of Akt/mTOR/FoxO3a Signaling Pathways and the Inhibition of Low-Grade Chronic Inflammation in Aged Mice

As populations around the world age, interest in healthy aging is growing. One of the first physical changes that occurs with aging is the loss of muscle mass and strength, termed sarcopenia. Sarcopenia limits the activity of older people, reduces their quality of life, and increases the likelihood...

Full description

Bibliographic Details
Main Authors: Hyun-Ji Oh, Heegu Jin, Jeong-Yong Lee, Boo-Yong Lee
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/12/18/2257
_version_ 1827726720614006784
author Hyun-Ji Oh
Heegu Jin
Jeong-Yong Lee
Boo-Yong Lee
author_facet Hyun-Ji Oh
Heegu Jin
Jeong-Yong Lee
Boo-Yong Lee
author_sort Hyun-Ji Oh
collection DOAJ
description As populations around the world age, interest in healthy aging is growing. One of the first physical changes that occurs with aging is the loss of muscle mass and strength, termed sarcopenia. Sarcopenia limits the activity of older people, reduces their quality of life, and increases the likelihood of their developing disease. In the present study, we aimed to evaluate the effects of the ingestion of acid-hydrolyzed silk peptide (SP) on the muscle mass and strength of mice of >22 months of age with naturally occurring sarcopenia, and to identify the mechanisms involved. The daily administration of SP for 8 weeks increased the activation of the Akt/mTOR/FoxO3a signaling pathways and increased the muscle mass and strength of the old mice. In addition, SP inhibited oxidative stress and inflammation in muscle, which are direct causes of sarcopenia. Therefore, SP represents a promising potential treatment for sarcopenia that may improve the healthy lifespan and quality of life of older people.
first_indexed 2024-03-10T22:55:54Z
format Article
id doaj.art-06e374988a364c87a6cc44884bbd84f5
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-10T22:55:54Z
publishDate 2023-09-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-06e374988a364c87a6cc44884bbd84f52023-11-19T09:59:31ZengMDPI AGCells2073-44092023-09-011218225710.3390/cells12182257Silk Peptide Ameliorates Sarcopenia through the Regulation of Akt/mTOR/FoxO3a Signaling Pathways and the Inhibition of Low-Grade Chronic Inflammation in Aged MiceHyun-Ji Oh0Heegu Jin1Jeong-Yong Lee2Boo-Yong Lee3Department of Food Science and Biotechnology, College of Life Science, CHA University, Seongnam 13488, Republic of KoreaDepartment of Food Science and Biotechnology, College of Life Science, CHA University, Seongnam 13488, Republic of KoreaWorldway Co., Ltd., Sejong 30003, Republic of KoreaDepartment of Food Science and Biotechnology, College of Life Science, CHA University, Seongnam 13488, Republic of KoreaAs populations around the world age, interest in healthy aging is growing. One of the first physical changes that occurs with aging is the loss of muscle mass and strength, termed sarcopenia. Sarcopenia limits the activity of older people, reduces their quality of life, and increases the likelihood of their developing disease. In the present study, we aimed to evaluate the effects of the ingestion of acid-hydrolyzed silk peptide (SP) on the muscle mass and strength of mice of >22 months of age with naturally occurring sarcopenia, and to identify the mechanisms involved. The daily administration of SP for 8 weeks increased the activation of the Akt/mTOR/FoxO3a signaling pathways and increased the muscle mass and strength of the old mice. In addition, SP inhibited oxidative stress and inflammation in muscle, which are direct causes of sarcopenia. Therefore, SP represents a promising potential treatment for sarcopenia that may improve the healthy lifespan and quality of life of older people.https://www.mdpi.com/2073-4409/12/18/2257acid-hydrolyzed silk peptidesarcopeniaAktmTORFoxO3asignaling pathway
spellingShingle Hyun-Ji Oh
Heegu Jin
Jeong-Yong Lee
Boo-Yong Lee
Silk Peptide Ameliorates Sarcopenia through the Regulation of Akt/mTOR/FoxO3a Signaling Pathways and the Inhibition of Low-Grade Chronic Inflammation in Aged Mice
Cells
acid-hydrolyzed silk peptide
sarcopenia
Akt
mTOR
FoxO3a
signaling pathway
title Silk Peptide Ameliorates Sarcopenia through the Regulation of Akt/mTOR/FoxO3a Signaling Pathways and the Inhibition of Low-Grade Chronic Inflammation in Aged Mice
title_full Silk Peptide Ameliorates Sarcopenia through the Regulation of Akt/mTOR/FoxO3a Signaling Pathways and the Inhibition of Low-Grade Chronic Inflammation in Aged Mice
title_fullStr Silk Peptide Ameliorates Sarcopenia through the Regulation of Akt/mTOR/FoxO3a Signaling Pathways and the Inhibition of Low-Grade Chronic Inflammation in Aged Mice
title_full_unstemmed Silk Peptide Ameliorates Sarcopenia through the Regulation of Akt/mTOR/FoxO3a Signaling Pathways and the Inhibition of Low-Grade Chronic Inflammation in Aged Mice
title_short Silk Peptide Ameliorates Sarcopenia through the Regulation of Akt/mTOR/FoxO3a Signaling Pathways and the Inhibition of Low-Grade Chronic Inflammation in Aged Mice
title_sort silk peptide ameliorates sarcopenia through the regulation of akt mtor foxo3a signaling pathways and the inhibition of low grade chronic inflammation in aged mice
topic acid-hydrolyzed silk peptide
sarcopenia
Akt
mTOR
FoxO3a
signaling pathway
url https://www.mdpi.com/2073-4409/12/18/2257
work_keys_str_mv AT hyunjioh silkpeptideamelioratessarcopeniathroughtheregulationofaktmtorfoxo3asignalingpathwaysandtheinhibitionoflowgradechronicinflammationinagedmice
AT heegujin silkpeptideamelioratessarcopeniathroughtheregulationofaktmtorfoxo3asignalingpathwaysandtheinhibitionoflowgradechronicinflammationinagedmice
AT jeongyonglee silkpeptideamelioratessarcopeniathroughtheregulationofaktmtorfoxo3asignalingpathwaysandtheinhibitionoflowgradechronicinflammationinagedmice
AT booyonglee silkpeptideamelioratessarcopeniathroughtheregulationofaktmtorfoxo3asignalingpathwaysandtheinhibitionoflowgradechronicinflammationinagedmice